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Abstract
The zinc finger transcription factor GATA6 is believed to have important roles in the development
of several organs including the liver, gastrointestinal tract and heart. However, analyses of the
contribution of GATA6 toward organogenesis have been hampered because Gata6-/- mice fail to
develop beyond gastrulation due to defects in extraembryonic endoderm function. We have
therefore generated a mouse line harbouring a conditional loss-of-function allele of Gata6 using Cre/
loxP technology.
LoxP elements were introduced into introns flanking exon 2 of the Gata6 gene by homologous
recombination in ES cells. Mice containing this altered allele were bred to homozygosity and were
found to be viable and fertile. To assess the functional integrity of the loxP sites and to confirm that
we had generated a Gata6 loss-of-function allele, we bred Gata6 'floxed' mice to EIIa-Cre mice in
which Cre is ubiquitously expressed, and to Villin-Cre mice that express Cre in the epithelial cells
of the intestine. We conclude that we have generated a line of mice in which GATA6 activity can
be ablated in a cell type specific manner by expression of Cre recombinase. This line of mice can
be used to establish the role of GATA6 in regulating embryonic development and various aspects
of mammalian physiology.
Background
The mouse Gata6 gene encodes a 45 kD protein contain-
ing two highly conserved zinc-finger DNA binding
domains with a Cys-X2-Cys-X17-Cys-X2-Cys motif that
directs binding to the nucleotide sequence element (A/
T)GATA(A/G) . GATA4, 5 and 6 make up a subset of
GATA factors that have been implicated in the develop-
ment of several organs including the heart, lung, gas-
trointestinal tract and liver [1-4]. Development of
GATA6 null embryos arrests during gastrulation as a
consequence of defects in extraembryonic endoderm
function [2,5]. This early embryonic lethality can be res-
cued by complementing the GATA6 null embryos with a
wild type extraembryonic visceral endoderm using tetra-
ploid embryo complementation, and embryos derived
by this process can survive until E10.5 [3]. Analyses of
such  Gata6-/-ES cell-derived embryos has revealed
defects in hepatogenesis, which supports the proposal
that GATA6 is an important developmental regulator.
Although the ability to generate embryos from Gata6-/-
ES cells by tetraploid embryo complementation has pro-
vided important insight into the contribution of GATA6
during early embryogenesis, this approach is not com-
patible with studying the role of GATA6 at later stages in
development or its role in controlling differentiation of
specific cell types. In the current report, we describe the
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generation of mice containing a conditional null allele
of Gata6 that can be used for cell type-specific removal
of GATA6 by Cre-mediated recombination.
Results and discussion
To ensure the elimination of GATA6 activity, we chose to
flank Gata6 exon 2 (based on nomenclature described by
Brewer et al [6,7]) with loxP elements because this exon
encodes the majority of the GATA6 protein (Fig. 1A). We
decided to use a recombineering approach to facilitate
the accurate placement of the loxP elements following
the procedure described by Lee et al [8]. The final target-
ing vector contained a loxP element located between
exons 2 and 3. In addition, a cassette containing a loxP
element lying immediately 5' to a neomycin phosphotrans-
ferase (neo) gene, which conferred resistance to G418,
was introduced between exons 1 and 2 (Fig. 1A). FRT
sites flanked the neo gene, in order to allow removal of
neo by Flp recombinase. Two novel restriction endonu-
clease cleavage sites (EcoRI and PacI) were also intro-
duced into the Gata6  targeting vector to allow the
identification of correctly modified Gata6  alleles by
Southern blot analyses. The targeting vector was intro-
duced into R1 ES cells [9] by electroporation, and G418-
resistant ES cell clones were tested for homologous
recombination at the Gata6 locus by Southern blot anal-
ysis. Fig. 1B shows an example of a correctly targeted ES
(Gata6loxP(FRTneoFRT)/+) cell line. Following digestion of ES
cell genomic DNA with EcoRI, a probe that lies 3' to the
short arm of homology used in the targeting vector iden-
tified an expected 8.1 kb wild type Gata6 DNA fragment,
while correctly targeted cells contain an additional 3.2 kb
fragment due to the introduction of a new EcoRI site.
When NdeI digested DNA was probed with a DNA frag-
ment lying 5' to the expected position of the introduced
loxP site, it identified the predicted 13.2 kb wild type
fragment and a novel 15.2 kb fragment, which resulted
from introducing the neo cassette into the Gata6 locus.
Five correctly targeted ES cell clones were recovered and
three of these cell lines were used to generate chimeric
mice by morula aggregation [10]. These chimeric ani-
mals were then mated with CD-1 mice and successful
germline transmission of the Gata6loxP(FRTneoFRT) allele was
confirmed by Southern blot analysis of tail DNA (Fig.
1B). Mice carrying a single Gata6loxP(FRTneoFRT)/+ allele were
viable and fertile. However, we were unable to obtain
mice that were homozygous for this allele, which sug-
gested that the inclusion of the neo cassette disrupted
GATA6 function and resulted in embryonic lethality as
observed for Gata6-/- embryos [2,5]. We therefore estab-
lished a mouse line, Gata6loxP/+, that lacked the neo cas-
sette by inducing recombination between the FRT sites in
vivo [11]. This was achieved by mating Gata6loxP(FRTneoFRT)/
+  mice to a transgenic mouse, B6;SJL-Tg(ACT-
FLPe)9205Dym/J, in which Flp recombinase is widely
expressed from the human beta actin gene promoter [11].
Correct excision of the neo cassette was confirmed in off-
spring by Southern blot and PCR analyses (Fig. 1B & C).
Gata6loxP/+  mice were finally interbred to generate
Gata6loxP/loxPmice, which are healthy, fertile and have
reached maturity.
We next addressed whether removal of GATA6 could be
induced in vivo by expression of Cre recombinase. We
chose to disrupt the Gata6 gene in the gastrointestinal
tract because it is highly expressed in the epithelium and
may have roles in controlling gut physiology or develop-
ment. To produce Gata6loxP/+Villin-Cre  mice, we bred
Gata6loxP/loxP  mice with transgenic mice (Tg(Vil-
cre)997Gum) in which Cre expression was directed to the
epithelial cells of the small intestine by the Villin (Vil1)
promoter [12]. Using this transgenic strain of mice, Cre
activity can be detected in the epithelium of the small
intestine from E14.5 [12]. Gata6loxP/+Villin-Cre males were
mated with Gata6loxP/loxP females to obtain Gata6loxP/+Vil-
lin-Cre  control and Gata6loxP/loxPVillin-Cre  experimental
offspring. In previous experiments, we observed that the
efficiency through which Cre mediates recombination
between  loxP sites varies between different transgenic
male mice [13]. We noted a similar situation when using
various Gata6loxP/+Villin-Cre males. In the majority of cases
(4/5 stud males) we were unable to obtain Gata6loxP/
loxPVillin-Cre offspring (n = 95 mice genotyped), and this
lethality associated with presumptive loss of GATA6 in the
intestine is currently under investigation. However, one
Gata6loxP/+Villin-Cre male did produce offspring (12/90)
whose genotype was determined to be Gata6loxP/loxPVillin-
Cre by PCR analysis of tail DNA. We, therefore, used RT-
PCR with Gata6  primers corresponding to nucleotide
sequences predicted to be deleted after recombination
between Gata6 loxP elements, to compare the steady-state
levels of Gata6 mRNA in intestines isolated from control
and experimental mice generated by this particular
Gata6loxP/+Villin-Cre male. Fig. 2A shows that Gata6 mRNA
could be detected in control intestine but not in intestine
isolated from a subset of Gata6loxP/loxPVillin-Cre offspring.
The remaining Gata6loxP/loxPVillin-Cre mice were found to
continue to express Gata6 mRNA at varying levels (data
not shown). We also examined expression of GATA6 pro-
tein in the intestines of Gata6loxP/loxPVillin-Cre  offspring
derived from the same Gata6loxP/+Villin-Cre male. Fig. 2B
shows that GATA6 was detected as an abundant nuclear
protein in the epithelial cells of control intestines. How-
ever,  Gata6loxP/loxP  Villin-Cre  mice displayed a marked
reduction in the abundance of intestinal GATA6 (Fig. 2B).
From these results, we conclude that the Gata6 gene can
be conditionally disrupted in Gata6loxP/loxP mice by cell-
type specific expression of Cre recombinase.BMC Developmental Biology 2006, 6:19 http://www.biomedcentral.com/1471-213X/6/19
Page 3 of 6
(page number not for citation purposes)
Generation of a Gata6 conditional null allele Figure 1
Generation of a Gata6 conditional null allele. (A) Schematic showing a map of the Gata6 genomic locus and the targeting 
vector with exons represented by open boxes. The relative position of Southern blot probes (lines), PCR primers (small 
arrowheads), loxP (large arrowheads) and FRT (ovals) sites, as well as cassettes encoding neomycin phosphotransferase (neo) 
and diphtheria toxin (DT), are included. Sizes of relevant EcoRI (e), NdeI (n), and PacI (p) restriction endonuclease fragments 
are shown in kilobase pairs (kb). (B) Southern blot analysis of genomic DNA isolated from ES cells (lanes 1, 2, 8 and 9) or 
mouse tails (lanes 3–7 and 10). An example of an ES cell line containing a correctly targeted Gata6loxP(FRTneoFRT) allele is shown in 
lanes 2 and 8. Mice harbouring the modified Gata6 allele were generated from these ES cells (lanes 3 and 10). Exon 2 of Gata6 
was deleted (Gata6del) or the neo cassette alone was deleted, leaving Gata6 exon 2 flanked by loxP elements (Gata6loxP), by 
breeding Gata6loxP(FRTneoFRT) mice to transgenic mice expressing either Cre (lane 6 and 7) or Flp (lane 4) recombinases, respec-
tively. The size of restriction fragments identified by 5' and 3' probes (Fig. 1A) was deduced from their position relative to 
standard DNA fragments. (C) The genotypes of mice and embryos were also determined by PCR amplification of genomic 
DNA. Primers were designed that differentiated between the Gata6+ (gt4F/4R; 159 bp), GataloxP (gt4F/4R; 250 bp) and Gata6del 
(k/o2F/2R; 568 bp) alleles, as well as neo (Neo A/B; 225 bp), flp (Flp F/R; 750 bp), and cre (Cre 1/2; 300 bp) transgenes.BMC Developmental Biology 2006, 6:19 http://www.biomedcentral.com/1471-213X/6/19
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Cre-mediated deletion of exon2 in Gata6loxP/loxP mice was
predicted to result in loss of GATA6 function. If this were
true, we expected that embryos homozygous for the
deleted allele (Gata6del) should undergo developmental
arrest, as was described for Gata6-/-  embryos [2,5].
Gata6del/+ mice were produced by mating Gata6loxP(FRTne-
oFRT)/+ mice with an EIIa-Cre transgenic mouse (B6.FVB-
Tg(EIIa-cre)C5379Lmgd/J). The EIIa-Cre mouse expresses
Cre recombinase in nearly all tissues, including those of
pre-implantation embryos, and has been used previously
to mediate recombination between loxP sites in germ cells
[14]. Gata6+/del progeny were identified by Southern blot
analyses of NdeI digested tail DNA. As shown in Fig. 1B,
Southern blots hybridized with the 5' Gata6 probe (Fig.
1A) revealed the conversion of a 15.2 kb NdeI fragment
from the Gata6loxP(FRTneoFRT) allele to an expected 12 kb
NdeI fragment from the Gata6del allele. Gata6+/del were then
mated inter se, and the genotype of embryos collected
between E8.5 and E11.5 was determined by PCR analysis
of genomic DNA. Of 77 embryos recovered, 27 were
Gata6+/+ and 50 were Gata6+/del (Table 1). In addition, 23
partially resorbed empty decidual masses were recovered,
which we believe likely resulted from the early develop-
mental arrest of Gata6del/del embryos. We finally deter-
mined whether the developmental lethality associated
with loss of GATA6 could be induced by expression of Cre
in pre-implantation embryos. To achieve this, Gata6loxP/
loxP mice were bred to Gata6+/delEIIa-Cre mice, which are
heterozygous for the EIIa-Cre transgene. The genotype of
resulting embryos ranging from E8.5 to E11.5 was again
determined by PCR. While we recovered 14 Gata6loxP/+, 18
Gata6loxP/del, and 16 Gata6loxP/+EIIaCre  embryos, no
Gata6loxP/delEIIaCre embryos were identified although 13
empty resorbing decidual masses were observed (Table 1).
Gata6 can be successfully ablated in the intestine of Gata6loxP/loxP mice by expression of Cre from the Villin promoter Figure 2
Gata6 can be successfully ablated in the intestine of Gata6loxP/loxP mice by expression of Cre from the Villin pro-
moter. (A) The steady-state level of Gata6 mRNA was compared in intestines isolated from four control Gata6loxP/+Villin-Cre 
(lanes 2–5) or experimental Gata6loxP/loxPVillin-Cre (lanes 6–9) mice. Amplification of Pol2 (Polr2a) mRNA showed that similar lev-
els of starting material were utilized in each reaction. (B) Immunohistochemistry showing that GATA6 was detected as an 
abundant nuclear protein in epithelial cells (arrows) of control intestines, but was detected at greatly reduced levels in 
Gata6loxP/loxPVillin-Cre intestines.BMC Developmental Biology 2006, 6:19 http://www.biomedcentral.com/1471-213X/6/19
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Conclusion
In summary, we conclude that we have generated a line of
mice in which GATA6 transcriptional activity can be
ablated by expression of Cre. We believe that the availabil-
ity of this mouse will be useful to elucidate the contribu-
tion of GATA6 during organogenesis as well as its
physiological role in adult mice.
Methods
Plasmid construction
A bacterial artificial chromosome (BAC # RP23-410I12)
that contained Gata6 genomic DNA was obtained from
BACPAC Resources, Children Hospital Research Institute,
Oakland, CA. Plasmid pNeb-DT-GATA6 was generated by
cloning a 12.2 kb EcoRV/PacI genomic fragment contain-
ing Gata6 exons 1 and 2 into the PacI/HincII site of a vec-
tor, pNEB193-DT, which contained a diphtheria toxin
(DT) expression cassette to enrich against random integra-
tion of the targeting plasmid in ES cells. A cassette con-
taining  loxP-neo-loxP  was amplified by PCR from the
plasmid pSV-LNL (modified from Zhang et al)[15] using
the following primers:
Gata6ET1:GCTTGCTGTTTGAGTCTACCCCATTTCTGCCT
GTTTCTTGACATCCCTTCGAATTCTGGTACCG-
GCGCGCCTAGTCGAC,
Gata6ET2:ATCCATTATTGTCAATGTCTAAAGATGGAATT
GTCTCTGCACAAGCTATCTTCTCAACTCGAGCCCT-
TAATTAACCGGT. These oligonucleotides contained 55
bp of sequence from Gata6 intron 2 (underlined). This
amplicon was introduced into Gata6 intron 2 sequence in
pNEB-DT-GATA6 by homologous recombination in E.coli
following the procedure described by Lee et al [8] The loxP-
neoloxP cassette was then converted to a single loxP site by
expression of Cre recombinase [8]. A loxP(FRTneoFRT)
cassette was then amplified from pSV-LFNF using primers
Gata6ET3:CACGCTGGTGGTTGTAAGGCGGTTTGTGTTT
AAGGTGTGCGGTTGGCCTGGACGTGTGGTACCG-
GCGCGCCTAGTCGAC,
Gata6ET4:GAAAAAGTTACCTAGCCCAGAGAAAGTGAGA
TGCCAGGAAAGGCATAAGGATATCAACTCGAGCCCT-
TAATTAACCGGT. These oligonucleotides contain 56 bp
(Gata6ET3) and 52 bp (Gata6ET4) of sequence from
Gata6 intron 1, respectively. This cassette was introduced
into Gata6 intron 1, again using homologous recombina-
tion in E.coli. to generate the final targeting vector (Fig.
1A).
ES cell targeting and animals
Linear targeting vector (100µg) was introduced into R1 ES
cells by electroporation, and the genotype of colonies
resistant to 350µg/ml of Geneticin (Gibco BRL) was deter-
mined by Southern blot (Fig. 1B). Chimeric mice were
generated by aggregation of ES cells with CD-1 morulae as
described previously [10] and the modified allele was
passed through the germline by breeding chimeras to
CD1 mice. Gata6loxP/loxP mice were produced by breeding
Gata6loxp(FRTneoFRT)/+  mice to B6;SJL-Tg(ACT-
FLPe)9205Dym/J mice [16] (Jackson Labs) to delete the
FRTneoFRT cassette by Flp-mediated recombination in the
germline. The ACTFLPe transgene was removed by breed-
ing F1 Gata6loxP/loxP mice into CD-1 mice. Gata6+/del mice
were generated by mating Gata6loxp(FRTneoFRT)/+  animals
with B6.FVB-Tg(EIIa-cre)C5379Lmgd/J transgenic mice
[17] (Jackson Labs) to allow Cre-mediate recombination
between loxP elements in the germline. The EIIa-Cre trans-
gene was removed by breeding Gata6+/del F1 mice with
CD1 mice. The MCW IACUC committee approved all pro-
cedures using animals.
Southern blot, PCR and RT-PCR
Southern blot analyses were performed using standard
conditions with probes indicated in Fig. 1. Genotypes
were determined by PCR using the following oligonucle-
otide primer pairs: Gata6 gt4F/4R, GTGGTTGTAAGGCG-
GTTTGT, ACGCGAGCTCCAGAAAAAGT; Gata6 k/o2F/2R,
AGTCTCCCTGTCATTCTTCCTGCTC, TGATCAAACCT-
GGGTCTACACTCCTA;  Flp F/R, GGTCCAACT-
GCAGCCCAAGCTTCC,
GTGGATCGATCCTACCCCTTGCG [16]; Cre 1/2, GTTCG-
CAAGAACCTGATGGACA, CTAGAGCCTGTTTT-
GCACGTTC [18]; Neo A/B,
GCCAACGCTATGTCCTGATAGCGGT, AGCCGGTCTT-
GTCGATCAGGATGAT. RT-PCR was performed as
described previously [19] with the following primer pairs:
Gata6 9/10; AGTTTTCCGGCAGAGCAGTA, AGTCAAG-
GCCATCCACTGTC,  Pol2 F/R; CTGATGCGGGTGCT-
GAGTGAGAAGG, GCGGTTGACCCCATGACGAGTG.
Immunohistochemistry
Immunohistochemistry was performed using antigen
retrieval in citrate buffer as described previously [13]
using an anti-GATA6 antibody (AF1700 R&D Systems,1/
1000 dilution).
Abbreviations
Neo, neomycin phosphotransferase
Table 1: Embryonic lethality associated with loss of GATA6 
function
Gata6+/del X Gata6+/del Gata6loxP/loxP X Gata6+/del EIIa-Cre
genotype E8.5 – 11.5 
embryos
genotype E8.5 – 11.5 
embryos
+/+ 27 loxP/+ 14
+/del 50 loxP/+ EIIa-Cre 16
del/del 0 loxP/del 18
resorbed 23 loxP/del EIIa-Cre 0
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